Lack of direct interaction between enalaprilat and the kinin B1 receptors

Peptides

Volumn 29, Issue 4, 2008, Pages 606-612

  Morissette, Guillaume ^a   Couture, Jean Philippe ^a   Désormeaux, Anik ^b   Adam, Albert ^b   Marceau, François ^a  

^a LAVAL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Angiotensin converting enzyme; Binding assay; Bradykinin B1 receptor; Enalaprilat

Indexed keywords

ARGININE; BRADYKININ B1 RECEPTOR; CALCIUM; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRILAT; GLYCINE DERIVATIVE; HIPPURYLGLYCYLGLYCINE; LYSINE; RADIOLIGAND; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CALCIUM SIGNALING; CELL MEMBRANE; CONTROLLED STUDY; DRUG PROTEIN BINDING; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HYDROLYSIS; ISOTOPE LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; UMBILICAL VEIN;

EID: 40249113251     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2007.12.004     Document Type: Article

References (32)

1. J.V. Gainer J.D. Morrow A. Loveland D.J. King N.J. Brown Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects N Engl J Med 339 1998 1285 1292
2. I.B. Squire K.P. O’Kane N. Anderson J.L. Reid Bradykinin B2 receptor antagonism attenuates blood pressure response to acute angiotensin-converting enzyme inhibition in normal men Hypertension 36 2000 132 136
3. M. Pretorius D. Rosenbaum D.E. Vaughan N.J. Brown Angiotensin-converting enzyme inhibition increases human vascular tissue-type plasminogen activator release through endogenous bradykinin Circulation 107 2003 579 585
4. M.E. Moreau N. Garbacki G. Molinaro N.J. Brown F. Marceau A. Adam The kallikrein–kinin system: current and future pharmacological targets J Pharmacol Sci 99 2005 6 38
5. J. Lefebvre A. Shintani T. Gebretsadik J.R. Petro L.J. Murphey N.J. Brown Bradykinin B2 receptor does not contribute to blood pressure lowering during AT1 receptor blockade J Pharmacol Exp Ther 320 2007 1261 1267
6. L.M.F. Leeb-Lundberg F. Marceau W. Müller-Esterl D.J. Pettibone B.L. Zuraw International Union of Pharmacology XLV. Classification of the kinin receptor family: from molecular mechanisms to pathophysiological consequences Pharmacol Rev 57 2005 27 77
7. 1 receptor J Biol Chem 277 2002 16847 16852
8. T. Ignjatovic S. Stanisavljevic V. Brovkovych R.A. Skidgel E.G. Erdos Kinin B1 receptors stimulate nitric oxide production in endothelial cells: signaling pathways activated by angiotensin I-converting enzyme inhibitors and peptide ligands Mol Pharmacol 66 2004 1310 1316
9. S. Stanisavljevic T. Ignjatovic P.A. Deddish V. Brovkovych K. Zhang E.G. Erdos Angiotensin I-converting enzyme inhibitors block protein kinase C epsilon by activating bradykinin B1 receptors in human endothelial cells J Pharmacol Exp Ther 316 2006 1153 1158
10. J.P. Fortin F. Gobeil Jr. A. Adam D. Regoli F. Marceau Do angiotensin-converting enzyme inhibitors directly stimulate the kinin B1 receptor? Am J Physiol Heart Circ Physiol 285 2003 H277 H282
11. G. Morissette F. Marceau Molecular identification and pharmacological profile of the bovine kinin B1 receptor Biol Chem 387 2006 211 215
12. L. Wei F. Alhenc-Gelas F. Soubrier A. Michaud P. Corvol E. Clauser Expression and characterization of recombinant human angiotensin I-converting enzyme. Evidence for a C-terminal transmembrane anchor and for a proteolytic processing of the secreted recombinant and plasma enzymes J Biol Chem 266 1991 5540 5546
13. O. Boussif F. Lezoualc’h M.A. Zanta M.D. Mergny D. Scherman B. Demeneix A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine Proc Natl Acad Sci USA 92 1995 7297 7301
14. A. Gautam C.L. Densmore E. Golunski B. Xu J.C. Waldrep Transgene expression in mouse airway epithelium by aerosol gene therapy with PEI-DNA complexes Mol Ther 3 2001 551 556
15. W.T. Godbey K.K. Wu A.G. Mikos Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle J Biomed Mater Res 45 1999 268 275
16. 1 receptor in human vascular smooth muscle cells Mol Pharmacol 71 2007 949 956
17. J. Huot F. Houle F. Marceau J. Landry Oxidative stress-induced actin reorganization mediated by the p38 mitogen-activated protein kinase/heat shock protein 27 pathway in vascular endothelial cells Circ Res 80 1997 383 392
18. 1 receptor to caveolae-related rafts Mol Pharmacol 61 2002 546 553
19. R.J. Tallarida R.B. Murray Manual of Pharmacologic Calculations with Computer Programs 1987 Springer-Verlag New York
20. 2 receptor Hypertension 35 2000 1319 1325
21. 2 receptors Br J Pharmacol 150 2007 369 379
22. 1 receptor: effects at the rabbit receptor J Pharmacol Exp Ther 311 2004 1121 1130
23. 1 receptor antagonism J Pharmacol Exp Ther 317 2006 300 308
24. D.J. Campbell Vasopeptidase inhibition: a double-edged sword? Hypertension 41 2003 383 389
25. L. Wei E. Clauser F. Alhenc-Gelas P. Corvol The two homologous domains of human angiotensin I-converting enzyme interact differently with competitive inhibitors J Biol Chem 267 1992 13398 13405
26. K. Yayama N. Kunimatsu Y. Teranishi M. Takano H. Okamoto Tissue kallikrein is synthetized and secreted by human vascular endothelial cells Biochim Biophys Acta 1593 2003 231 238
27. A. Sulpizio M.A. Pullen R.M. Edwards D.P. Brooks The effect of acute angiotensin converting enzyme and neutral endopeptidase 24,11 inhibition on plasma extravasation in the rat J Pharmacol Exp Ther 309 2004 1141 1147
28. S.N. Ha P.J. Hey R.W. Ransom M.G. Bock D.S. Su K.L. Murphy Identification of the critical residues of bradykinin receptor B1 for interaction with the kinin guided by site-directed mutagenesis and molecular modeling Biochemistry 45 2006 14355 14361
29. 1-receptors in normotensive rats and mice under chronic angiotensin-converting enzyme inhibitor treatment Circulation 105 2002 627 632
30. M.E. Moreau P. Dubreuil G. Molinaro M. Chagnon W. Müller-Esterl Y. Lepage Expression of metallopeptidases and kinin receptors in swine oropharyngeal tissue: effect of ACE inhibition and inflammation J Pharmacol Exp Ther 315 2005 1065 1074
31. 9-bradykinin metabolic pathways and kinetics of activation of human plasma Am J Physiol Heart Circ Physiol 281 2001 H275 H283
32. I. Fleming Signaling by the angiotensin-converting enzyme Circ Res 98 2006 887 896